The UCL spinout has priced its shares at the top of its range and secured $150m in proceeds, up from its initial target of $100m.

The Northwestern University-backed neurologic disorder therapy developer floated at the top of its range, increasing the share volume at the same time.

The Nan Fung-backed neurologic disorder therapy developer floated at the top of its range, increasing the share volume at the same time.

EMS-backed gene therapy developer AvroBio has secured $99.7m in an initial public offering that could potentially rise to $115m.

Qualcomm, China Mobile and SF Express are among seven cornerstone investors that will buy 10% of the shares in the Hong Kong offering.

The Salesforce and WPP-backed business data platform has set the range for an offering that would raise $202m at the top of its range.

The Alphabet and Salesforce-backed online survey platform, valued at $2bn as of 2014, has revealed it has confidentially filed to go public.

Rocket Internet remains the largest investor in the home products marketplace, which has floated in a $174m initial public offering.

Uxin has set its pricing range at $10.50 to $12.50 per American Depositary Share, with Baidu, Legend Holdings and Tencent all in line to exit the used vehicle marketplace.